Acriflavine Inhibits Acquired Drug Resistance by Blocking the Epithelial-to-Mesenchymal Transition and the Unfolded Protein Response  Jeroen Dekervel,

Slides:



Advertisements
Similar presentations
Mesenchymal Stem Cell Conditioned Medium Promotes Proliferation and Migration of Alveolar Epithelial Cells under Septic Conditions In Vitro via.
Advertisements

Volume 36, Issue 6, Pages (June 2015)
Volume 124, Issue 7, Pages (June 2003)
Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells  Chiara Laezza, Alba D’Alessandro, Simona Paladino, Anna.
Volume 355, Issue 2, Pages (December 2014)
HMGA2 Maintains Oncogenic RAS-Induced Epithelial-Mesenchymal Transition in Human Pancreatic Cancer Cells  Sugiko Watanabe, Yasuaki Ueda, Shin-ichi Akaboshi,
Platelet-Derived Growth Factor-BB Mediates Cell Migration through Induction of Activating Transcription Factor 4 and Tenascin-C  Kristine P. Malabanan,
Molecular Therapy - Oncolytics
From: β-Catenin/CBP–Dependent Signaling Regulates TGF-β–Induced Epithelial to Mesenchymal Transition of Lens Epithelial Cells Invest. Ophthalmol. Vis.
Inhibition of hypoxia-induced cyclooxygenase-2 by Korean Red Ginseng is dependent on peroxisome proliferator-activated receptor gamma  Heewon Song, Young.
Cyclin-Dependent Kinase 2 Promotes Tumor Proliferation and Induces Radio Resistance in Glioblastoma  Jia Wang, Tong Yang, Gaofeng Xu, Hao Liu, Chunying.
A Signal Transduction Pathway from TGF-β1 to SKP2 via Akt1 and c-Myc and its Correlation with Progression in Human Melanoma  Xuan Qu, Liangliang Shen,
The Chemokine Receptor CXCR4 and c-MET Cooperatively Promote Epithelial- Mesenchymal Transition in Gastric Cancer Cells  Yu Cheng, Yongxi Song, Jinglei.
Membrane-Tethered Intracellular Domain of Amphiregulin Promotes Keratinocyte Proliferation  Stefan W. Stoll, Philip E. Stuart, Sylviane Lambert, Alberto.
Induction of Neuroendocrine Differentiation in Prostate Cancer Cells by Dovitinib (TKI- 258) and its Therapeutic Implications  Shalini S. Yadav, Jinyi.
Up-Regulation of RFC3 Promotes Triple Negative Breast Cancer Metastasis and is Associated With Poor Prognosis Via EMT  Zhen-Yu He, San-Gang Wu, Fang Peng,
SDHB deficiency promotes TGFβ-mediated invasion and metastasis of colorectal cancer through transcriptional repression complex SNAIL1-SMAD3/4  Haiyu Wang,
Droxinostat, a Histone Deacetylase Inhibitor, Induces Apoptosis in Hepatocellular Carcinoma Cell Lines via Activation of the Mitochondrial Pathway and.
A Novel IMP1 Inhibitor, BTYNB, Targets c-Myc and Inhibits Melanoma and Ovarian Cancer Cell Proliferation  Lily Mahapatra, Neal Andruska, Chengjian Mao,
IFN-γ Induces Gastric Cancer Cell Proliferation and Metastasis Through Upregulation of Integrin β3-Mediated NF-κB Signaling  Yuan-Hua Xu, Zheng-Li Li,
Myocardin-Related Transcription Factors A and B Are Key Regulators of TGF-β1- Induced Fibroblast to Myofibroblast Differentiation  Beverly J. Crider, George.
Chandra M.V. Goparaju, PhD  Journal of Thoracic Oncology 
Restoration of Corneal Transparency by Mesenchymal Stem Cells
Requirement of Zinc Transporter SLC39A7/ZIP7 for Dermal Development to Fine-Tune Endoplasmic Reticulum Function by Regulating Protein Disulfide Isomerase 
Verena N. Lorenz, Michael P. Schön, Cornelia S. Seitz 
Interferon-γ Protects from Staphylococcal Alpha Toxin-Induced Keratinocyte Death through Apolipoprotein L1  Anne M. Brauweiler, Elena Goleva, Donald Y.M.
Identifying Inhibitors of Epithelial-Mesenchymal Transition by Connectivity Map–Based Systems Approach  Ajaya Kumar Reka, PhD, Rork Kuick, MS, Himabindu.
Insulin-Like Growth Factor-I Enhances Transforming Growth Factor-β-Induced Extracellular Matrix Protein Production Through the P38/Activating Transcription.
Pulmonary Fibroblasts Induce Epithelial Mesenchymal Transition and Some Characteristics of Stem Cells in Non-Small Cell Lung Cancer  Yasushi Shintani,
SOX10 Promotes Melanoma Cell Invasion by Regulating Melanoma Inhibitory Activity  Saskia A. Graf, Christian Busch, Anja-Katrin Bosserhoff, Robert Besch,
Volume 7, Issue 1, Pages e7 (July 2018)
Volume 143, Issue 6, Pages e5 (December 2012)
Glucosamine promotes chondrogenic phenotype in both chondrocytes and mesenchymal stem cells and inhibits MMP-13 expression and matrix degradation  A.
Transdifferentiation of Melanoma Cells by the Reprogramming Factors Attenuates Malignant Nature In Vitro and In Vivo  Mikiro Takaishi, Shigetoshi Sano 
Spleen Tyrosine Kinase Mediates EGFR Signaling to Regulate Keratinocyte Terminal Differentiation  Nan-Lin Wu, Duen-Yi Huang, Li-Fang Wang, Reiji Kannagi,
Stefan W. Stoll, Jessica L. Johnson, Yong Li, Laure Rittié, James T
Volume 56, Issue 4, Pages (October 1999)
Tumor necrosis factor α up-regulates endometrial milk fat globule–epidermal growth factor 8 protein production via nuclear factor κB activation, resulting.
AT-101, a Pan-Bcl-2 Inhibitor, Leads to Radiosensitization of Non-small Cell Lung Cancer  Luigi Moretti, MD, Bo Li, MD, Kwang Woon Kim, PhD, Heidi Chen,
Molecular Therapy - Nucleic Acids
Inhibition of PI3K-AKT-mTOR Signaling Sensitizes Melanoma Cells to Cisplatin and Temozolomide  Tobias Sinnberg, Konstantinos Lasithiotakis, Heike Niessner,
Volume 10, Issue 8, Pages (March 2015)
Volume 9, Issue 3, Pages (September 2017)
Volume 23, Issue 10, Pages (October 2016)
Regulation of Skin Microvasculature Angiogenesis, Cell Migration, and Permeability by a Specific Inhibitor of PKCα  Sirosh M. Bokhari, Lisa Zhou, Marvin.
A predominantly articular cartilage-associated gene, SCRG1, is induced by glucocorticoid and stimulates chondrogenesis in vitro  Kensuke Ochi, M.D., Ph.D.,
Plexin B1 Suppresses c-Met in Melanoma: A Role for Plexin B1 as a Tumor-Suppressor Protein through Regulation of c-Met  Laurel Stevens, Lindy McClelland,
IL-6 Secreted from Cancer-Associated Fibroblasts Mediates Chemoresistance in NSCLC by Increasing Epithelial-Mesenchymal Transition Signaling  Yasushi.
Molecular Mechanisms Regulating the Defects in Fragile X Syndrome Neurons Derived from Human Pluripotent Stem Cells  Tomer Halevy, Christian Czech, Nissim.
Anne T. Funding, Claus Johansen, Matthias Gaestel, Bo M
Autologous chondrocyte implantation (ACI) for aged patients: development of the proper cell expansion conditions for possible therapeutic applications 
NADPH Oxidase 1 Overexpression Enhances Invasion via Matrix Metalloproteinase-2 and Epithelial–Mesenchymal Transition in Melanoma Cells  Feng Liu, Angela.
FOXO3a Is Activated in Response to Hypoxic Stress and Inhibits HIF1-Induced Apoptosis via Regulation of CITED2  Walbert J. Bakker, Isaac S. Harris, Tak.
Kellie J. White, Vincent J. Maffei, Marvin Newton-West, Robert A
Volume 138, Issue 4, Pages (April 2010)
Nrf2 Promotes Keratinocyte Proliferation in Psoriasis through Up-Regulation of Keratin 6, Keratin 16, and Keratin 17  Luting Yang, Xueli Fan, Tingting.
Volume 8, Issue 5, Pages (May 2017)
Transforming Growth Factor β1 Induces Apoptosis in Normal Melanocytes but not in Nevus Cells Grown in Type I Collagen Gel  Tuomo Alanko  Journal of Investigative.
Nestin expression in the kidney with an obstructed ureter
Collagen Synthesis Is Suppressed in Dermal Fibroblasts by the Human Antimicrobial Peptide LL-37  Hyun Jeong Park, Dae Ho Cho, Hee Jung Kim, Jun Young.
Volume 21, Issue 4, Pages (October 2017)
Volume 122, Issue 2, Pages (February 2002)
Epithelial to Mesenchymal Transition in an Epidermal Growth Factor Receptor-Mutant Lung Cancer Cell Line with Acquired Resistance to Erlotinib  Kenichi.
MELK Promotes Melanoma Growth by Stimulating the NF-κB Pathway
Sorafenib inhibits growth, migration, and angiogenic potential of ectopic endometrial mesenchymal stem cells derived from patients with endometriosis 
Volume 12, Issue 1, Pages (January 2019)
Marijn T.M. van Jaarsveld, Difan Deng, Erik A.C. Wiemer, Zhike Zi 
Slug/Snai2 Is a Downstream Mediator of Epidermal Growth Factor Receptor-Stimulated Reepithelialization  Donna F. Kusewitt, Changsun Choi, Kimberly M.
Molecular Therapy - Oncolytics
Condensin and Hmo1 Mediate a Starvation-Induced Transcriptional Position Effect within the Ribosomal DNA Array  Danni Wang, Andres Mansisidor, Gayathri.
Presentation transcript:

Acriflavine Inhibits Acquired Drug Resistance by Blocking the Epithelial-to-Mesenchymal Transition and the Unfolded Protein Response  Jeroen Dekervel, Ashenafi Bulle, Petra Windmolders, Diether Lambrechts, Eric Van Cutsem, Chris Verslype, Jos van Pelt  Translational Oncology  Volume 10, Issue 1, Pages 59-69 (February 2017) DOI: 10.1016/j.tranon.2016.11.008 Copyright © 2016 The Authors Terms and Conditions

Figure 1 Morphological changes in the different EMT models before and after treatment with ACF. Cells were cultured in their appropriate medium. EMT was induced using TGF-β1 or CoCl2 after 24 hour pretreatment with medium of 1% FCS (for Panc-1 cells) or after development of resistance against sorafenib (HepG2S1). Effect of ACF on morphology were observed under phase-contrast microscope on cells co-treated with a non-lethal dose of 2.5 μM ACF. The arrows indicate spindle shaped cells a morphological feature of EMT. Scale bars represent 200 μm. (For details see materials and methods). Translational Oncology 2017 10, 59-69DOI: (10.1016/j.tranon.2016.11.008) Copyright © 2016 The Authors Terms and Conditions

Figure 2 Invasive capacities of the EMT models before and after treatment with ACF. Invasion studies were performed as described in materials and method section. After 48 hours the cells that had invaded were fixed, stained and counted. The results are the mean of 3 biological repeats +/− SD. On the right side representative pictures of the microscopic view of the matrigel are given. Original magnification 10×, *: P<.001. Translational Oncology 2017 10, 59-69DOI: (10.1016/j.tranon.2016.11.008) Copyright © 2016 The Authors Terms and Conditions

Figure 3 Gene and protein expression analysis in models of EMT with and without treatment with ACF. (A) Gene expression was determined in the Panc-1/TGF-β1 model. After 24 hours of growth in medium with 1% FCS followed by 48 hours stimulation with or without ACF the cells were harvested and qRT-PCR performed. (B) Protein expression by Western blot of marker genes for EMT: E-cadherin, Vimentin and Snai1. Representative blots are shown here. (C) Gene expression by qRT-PCR of sorafenib-resistant HepG2S1 cells treated with different concentrations of ACF for 24 hours. (D) ACF restores the expression of a significant fraction of genes in the EMT models. We analyzed the genes that were differentially expressed by TGF-β1 or CoCl2 treatment in Panc-1 cells for the effect of co-treatment with ACF using transcriptome data. Upon TGF-β1 stimulation 421 genes were significantly changed in expression (2log change > +1 or <−1 and pcorr<0.05). Of these, ACF restored 45% of differentially expressed genes (top). In the CoCl2 stimulated cells we found 611 genes to be differentially expressed, here ACF restored 35% (bottom). All experiments were performed in 3 biological repeats. qRT-PCR results are given as mean fold change +/− SD. (*: P<.05, **: P<.01, ***: P<.001 and ****: P<.0001). Translational Oncology 2017 10, 59-69DOI: (10.1016/j.tranon.2016.11.008) Copyright © 2016 The Authors Terms and Conditions

Figure 4 ACF partially restores drug sensitivity in models of acquired resistance. Dose dependent cell death was investigated using XTT assay as described in materials and methods. A) Sensitivity of HepG2 and derived sorafenib-resistant HepG2S1 cells to ACF. B) ACF at a non-lethal dose restores sorafenib sensitivity in HepG2S1 cells. C) Sensitivity of MiaPaCa-2 and derived gemcitabine resistant cell line GR800 to ACF. D) Similarly, ACF restores gemcitabine sensitivity in GR800 cells. Translational Oncology 2017 10, 59-69DOI: (10.1016/j.tranon.2016.11.008) Copyright © 2016 The Authors Terms and Conditions

Figure 5 ACF inhibits the unfolded protein response and ATF4 transcriptional program. Transcriptome data were analyzed using two software programs iRegulon and GSEA. (A) GSEA analysis ranked unfolded protein response (upper row) and ATF4 targets (lower row) in Panc-1 cells and HepG2S1 models as highly significantly enriched upon treatment with ACF. (B) iRegulon identifies ATF4, ATF3 or CEBPB as regulating transcription factor in the working mechanism of ACF in Panc-1 and HepG2S1 cells. (C) ATF4 targets significantly down-regulated by ACF in Panc-1 cells, HepG2S1 cells or both. (AUC, area under the curve; NES, normalized enrichment score). Translational Oncology 2017 10, 59-69DOI: (10.1016/j.tranon.2016.11.008) Copyright © 2016 The Authors Terms and Conditions

Figure 6 ACF inhibits UPR in Panc-1 model induced by CoCl2. (A) GSEA analysis of the transcriptome data showed that ACF inhibits UPR induced by CoCl2. CoCl2 stimulation leads to ATF4 activation which is abrogated by concomitant ACF treatment. (B) ATF4 mRNA levels and its target gene CA-9 are up-regulated by CoCl2 and restored to baseline by ACF. (C) On Western blot, phosphorylation of eIF2a caused by either CoCl2 or TGF-β1 is inhibited by ACF. D) tRNA synthetases are induced by CoCl2 treatment and down-regulated by ACF. Numbers represent FPKM (Fragments Per Kilobase Million) values. Translational Oncology 2017 10, 59-69DOI: (10.1016/j.tranon.2016.11.008) Copyright © 2016 The Authors Terms and Conditions